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Adherence of uropathogenic Escherichia coli to host tissue is required for infection and is mediated by
fimbriae, such as pyelonephritis-associated pili (Pap). Expression of P fimbriae is regulated by phase variation,
and to date, phase transition frequencies have been measured only for pap regulatory region constructs
integrated into the E. coli K-12 chromosome. The aim of this work was to measure P phase transition
frequencies in clinical isolates for the first time, including frequencies for the sequenced strain E. coli CFT073.
P fimbriation and associated phase transition frequencies were measured for two E. coli clinical isolates and
compared with levels for homologous pap constructs in E. coli K-12. Fimbriation and off-to-on transition
frequencies were always higher in the clinical isolate. It was concluded that the regulatory inputs controlling
papI expression are likely to be different in E. coli CFT073 and E. coli K-12 as (i) phase variation could be
stimulated in E. coli K-12 by induction of papI and (ii) the level of expression of a papI::gfp fusion was higher
in E. coli CFT073 than in E. coli K-12. Furthermore, phase transition frequencies for the two E. coli CFT073
pap clusters were shown to be different depending on the culture conditions, indicating that there is a hierarchy
of expression depending on signal inputs.
Urinary tract infections (UTIs) are some of the most com-
mon human bacterial infections and are estimated to affect 150
million people worldwide and to cost more than $6 billion
annually in direct health care expenditures. These infections
include asymptomatic bacteriuria, cystitis, and acute pyelone-
phritis. The latter presents with severe clinical symptoms and
can result in renal scarring and renal failure in children (53).
Uropathogenic Escherichia coli (UPEC) is the leading cause of
UTIs and is responsible for up to 80% of uncomplicated cases
and more than 30% of nosocomial infections (8). The initial
colonization and persistence of E. coli in the urinary tract
require coordinated expression of multiple virulence factors,
including fimbriae, iron acquisition systems, and toxins. Fim-
brial adhesins promote colonization by binding to specific re-
ceptors on the surface of host cells. The type 1 fimbrial adhe-
sin, FimH, binds -D-mannose-containing receptors abundant
in the bladder (11), and PapG, the P fimbria tip adhesin,
recognizes kidney glycosphingolipids containing the Gal-(1-
4)-Gal moiety (26–28). Epidemiological studies have estab-
lished that there is a strong link between P fimbriae and pye-
lonephritis (3, 37), and recent studies have demonstrated that
P fimbriae can trigger proinflammatory cascades in the human
urinary tract (42, 51).
P fimbriae are encoded by the pyelonephritis-associated pi-
lus (pap) operon that contains the structural genes papA, -E,
-F, -G, and -H, the usher gene papC, the periplasmic chaper-
one gene papD, and genes encoding two regulators, papB and
papI (4, 45). UPEC isolates associated with symptomatic dis-
ease are more likely to contain multiple P fimbria operons (20).
Expression of P fimbriae is regulated in response to growth and
environmental conditions (2, 7, 16, 50) and is subject to phase
variation. Phase variation is dependent on a reversible epige-
netic switch that controls the initiation of transcription of the
pap operon genes, resulting in variable (on/off) expression of
the structural subunits (6, 7). The switch involves the formation
of protein complexes on one of two GATC methylation sites
present in the pap regulatory region (papI-papB intergenic
region). These GATC sites are distal (GATCdist) and proximal
(GATCprox) to the main operon promoter (PBA), are methyl-
ation targets for DNA adenine methylase (Dam), and overlap
two binding sites for the global regulator leucine-responsive
regulatory protein (Lrp) (9, 10). Competition between Dam
and Lrp for access to these sites results in two different meth-
ylation patterns that determine whether the pap operon is
transcriptionally on or off (48, 49). Formation of the phase-on
state also requires the pap-encoded regulator PapI, which is
transcribed by a separate divergent promoter (PI) upstream of
the main operon promoter (PBA). PapI has been shown to
favor Lrp binding to promoter distal sites when GATCprox is
methylated by Dam, promoting formation of the on phase (18,
24). A second pap-encoded protein, PapB, has been shown to
indirectly regulate pap phase variation by activating papI tran-
scription and to act as a transcriptional repressor at higher
concentrations by binding to sites overlapping the PBA pro-
moter and the papB coding sequence (14, 16).
Phase variation frequencies are important as they determine
the proportion of the population expressing fimbriae and also
govern expression of other surface factors at the single-cell
level through positive and negative cross talk (19–21, 52). P
fimbria phase variation frequencies have been studied exten-
sively using lysogenic reporter constructs in an E. coli K-12
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background (6, 7, 50), but little is known about pap phase
variation frequencies in clinical isolates. What is clear is that
the measured frequencies in E. coli K-12 are not predictive of
the high P fimbriation levels reported for several UPEC clin-
ical isolates (29, 34, 36).
In the current study, pap phase variation frequencies were
measured for the first time in a clinical isolate, the sequenced
strain E. coli CFT073, and were shown to be markedly higher
than the frequencies measured for the same operons in E. coli
K-12. The isolate background provides a regulatory context
that allows pap phase variation to occur at frequencies high
enough to account for the level of P fimbriation determined in
this study for E. coli CFT073. Phase variation frequencies were
determined for different environmental conditions, including
human urine, and were shown to be equivalent to those exhib-
ited in other bacterial phase-variable systems. Homologous
pap clusters in E. coli CFT073 were shown to be differentially
regulated, with cross talk between operons dependent on the
culture conditions.
MATERIALS AND METHODS
Bacterial strains and plasmids. Bacterial strains, plasmids, and primer se-
quences are listed in Table 1. All genetic cloning steps were carried out with E.
coli AAEC185A. E. coli CFT073 contains two Pap clusters, P1 and P2 (31), that
show 98% sequence identity across the complete regions (papI-papG) and 96.2%
identity across their regulatory regions (papI-papB). The F13 Pap cluster from E.
coli J96 (23) shares 91% identity with P1 and 92% identity with P2 of E. coli
CFT073 across the whole cluster and 96 and 95% identity, respectively, across
the papI-papB regulatory region. All plasmid transformations into E. coli
CFT073 (wild type and derivatives) were carried out by electroporation. The
following strategy was used to generate plasmids and strains for all single-copy
reporter fusions. First, DNA used for fusions was amplified by PCR and cloned
into BamHI-KpnI sites in exchange vectors containing either lacZ (pAJR36 and
pKC29) or gfp (pAJR28 and pKC47) reporters, flanked by DNA specific for K-12
(pAJR36 and pAJR28) or CFT073 (pKC29 and pKC47) backgrounds. The
primers used to generate clones are listed in Table 1. Second, the plasmids were
transformed into intermediate allelic-exchange strains (ZAP1164, ZAP957, and
ZAP964), and the fusions were integrated onto the chromosome by homologous
recombination and counterselection, as described previously (5, 12, 38). The
resulting strains are listed in Table 1. A similar strategy was used to generate
ZAP594, where pLD1 containing the complete F13 pap cluster was transformed
into AAEC090A and integrated into the MG1655 chromosome. Strain ZAP965
was generated through a series of intermediate strains (Table 1) to delete the
regulatory region from the 3 end of papI to the 5 end of papA for both P1 and
P2 operons of E. coli CFT073. The flanking regions incorporating papI were
amplified by PCR using primer P1UPfor (CFT073 P1) or P2UPfor (CFT073 P2)
together with P12SUPrev (both P1 and P2), and the flanking regions incorpo-
rating papA were amplified by PCR using P12DNfor (both P1 and P2) and
P1DNrev (CFT073 P1) or P2DNrev (CFT073 P2). The flanking regions were
cloned into the SacI/BamHI (papI) and BamHI/XbaI (papA) sites in pUC18 to
generate pNJH107 (CFT073 P1) and pNJH117 (CFT073 P2). The flanking
regions were subcloned into the SacI and XbaI sites in pIB307 and the sac-kan
cassette was cloned in the BamHI site to generate pMT11 (CFT073 P1) and
pMT17 (CFT073 P2). Plasmid pMT24 contains a transcriptional fusion of the
papI promoter to gfp and was generated by cloning the promoter region of papI
(primers papI P1for and papI P1rev) into the XbaI site of pKC26.
Culture conditions. The medium used for culturing strains and plasmids was
Luria-Bertani broth or agar (BDH Merck) supplemented with 25 g ml1
tetracycline, 25 g ml1 chloramphenicol, or 25 g ml1 ampicillin when nec-
essary. Colonization factor antigen (CFA) medium was used for optimal expres-
sion of P fimbriae (13). M9 medium contained M9 salts supplemented with
thiamine (20 mM), glycerol, or glucose (0.2%). Essential and nonessential amino
acids (Sigma-Aldrich, Dorset, United Kingdom) were added to generate rich
defined (RD) medium. Human urine was obtained from eight healthy volunteers
with no history of UTI or antibiotic usage in the previous 6 months. The urine
was pooled, filtered sterilized, stored in aliquots at 20°C, and used within 2
weeks. Urine was added at a final concentration of 0.5 to agar to make plates
or was used neat for static growth experiments.
Phase transition determination using lacZ reporter strains. To determine
phase transition frequencies under a number of different conditions, the follow-
ing strategy was used. Bacteria were grown on CFA agar containing 5-bromo-4-
chloro-3-indolyl--D-galactosylpyranoside (X-Gal) (40 g ml1) at 37°C, from
which either blue (mostly phase-on) or white (mostly phase-off) colonies were
picked, serially diluted in phosphate-buffered saline (PBS), and plated onto the
appropriate medium also containing X-Gal. At least six colonies from the various
media were then serially diluted in PBS and plated onto RD M9 medium with
glycerol and X-Gal to allow the proportions of phase-on and phase-off colonies
to be determined. The frequency of phase transition was calculated using the
equation used by Blyn et al. (7). Briefly, to determine the level of off-to-on
transition per cell per generation, the proportion of phase-on CFU was divided
by the number of generations that arose from the starting CFU. To determine
the on-to-off transition per cell per generation, the proportion of phase-off CFU
was used. The various conditions used were as follows: for phase transition on
rich undefined media, CFA agar containing X-Gal; for different environmental
conditions, minimal M9 medium with glycerol, RD M9 medium with glycerol, or
RD M9 medium with glucose; and for phase transition on urine, urine plates. To
determine the off-to-on phase transition in static urine, single colonies that were
phase off were selected from RD M9 medium containing glucose and diluted to
a concentration of approximately 5 CFU ml1 in PBS, and paired samples were
grown statically at 37°C in 5 ml urine or 5 ml RD M9 medium with glycerol for
24 h at 37°C. Bacteria were then serially diluted and plated onto RD M9 medium
with glycerol to determine the proportions of phase-on and phase-off bacteria.
The starting phase of the initial colonies was also determined by plating samples
onto RD M9 medium with glycerol. The colonies that were demonstrated to
contain 2% phase-on cells from RD M9 medium with glucose were excluded
from the analysis.
Indirect immunofluorescence assay for P fimbriae. For labeling P fimbriae on
the bacterial surface, UPEC colonies were collected from CFA agar plates after
overnight growth at 37°C using 3 ml of PBS. Bacterial suspensions having an
optical density at 600 nm of 0.6 were prepared and washed twice in 1 ml PBS and
then mixed with the appropriate primary anti-P rabbit polyclonal serum diluted
1:50 in PBS and incubated for 30 min at room temperature. For detection of F13
P fimbriae an anti-PapA antibody supplied by B. E. Uhlin was used, whereas for
detection of the E. coli CFT073 P1 and P2 fimbriae polyclonal serum provided by
T. Korhonen was used (OM12) (36). Different primary antibodies were used,
reflecting the different Pap types being detected. Excess primary antibody was
removed with three washes in 1 ml PBS, and cells were then mixed with the
secondary antibody goat Alexa Fluor 488 conjugated with anti-rabbit immuno-
globulin G (1:500 in PBS; Molecular Probes) for 30 min at room temperature.
Excess secondary antibody was removed with three washes in 1 ml PBS.
Flow cytometry and microscopy. Fluorescence from either serum-labeled P-
fimbriate bacteria or strains possessing a single-copy fluorescent reporter fusion
was detected using a FACSCalibur flow cytometer (Becton Dickinson). Acqui-
sition and analysis of flow cytometry data were performed using the CELLQuest
software. The selected R1 region was optimized in order to exclude small par-
ticles and debris using sized beads (Becton Dickinson) and multiple E. coli
strains. The gate for the detection of fluorescence signals was set such that cells
under investigation were considered positive when their fluorescence intensity
(FL-1 height) exceeded that of all but a very small fraction (0.5%) of the negative
control population of the same UPEC strain grown under the same conditions
but labeled with only the secondary antibody or the nonfluorescent parent of the
fusion strain. Fluorescence microscopy image acquisition and analysis were per-
formed using Improvision OpenLab software. Samples were prepared as de-
scribed above and fixed onto slides with 4% paraformaldehyde.
Whole-population fluorescence measurements. pKC26 and pMT24 were
transformed into AAEC185A, CFT073, and ZAP965, and single transformants
were cultured for approximately 18 h in CFA medium supplemented with 25 g
ml1 chloramphenicol. Samples were diluted to an optical density at 600 nm of
1.0, and replicate samples (200 l per well) were assayed with a Flurstar Optima
fluorimeter, using absorbance at 485 nm and emission at 520 nm, at a gain of
1,500. The results were corrected for background autofluorescence by subtrac-
tion of pKC26 levels at the equivalent optical densities.
RESULTS
Comparison of P fimbriation in UPEC clinical isolates with
a cloned pap operon in E. coli K-12. P fimbriation was mea-
sured in two well-characterized clinical E. coli UPEC isolates
that both contain two homologous pap operons, isolates J96
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TABLE 1. Strains, plasmids, and primers
Strain, plasmid,
or primer Genotype or sequence
Reference, source,
or use
Strains
AAEC185A F 	 supE44 hsdR17 mcrA endA1 thi-1 
(fimBEACDFGH) 
recA 5
MG1655 K-12 F 	 Guyer et al.a
J96 E. coli pyelonephritis isolate, pap prs 23
CFT073 E. coli pyelonephritis isolate, P1 pap, P2 pap 31
AAEC090A Intermediate allelic-exchange strain with sacB-neo cassette placed in the lac locus of
MG1655
5
ZAP593 Allelic exchange of papAJ96F13::lacZ from pLD7 in ZAP1164 This study
ZAP594 Allelic exchange of papJ96 F13 cluster from pLD1 in AAEC090A This study
ZAP595 Allelic exchange of papACFT072 P2::lacZ from pMT06 in ZAP964 This study
ZAP957 Intermediate allelic-exchange strain with sacB-neo cassette placed in the lac locus of CFT073 This study
ZAP714 Allelic exchange of papACFT073 P1::gfp from pMT01 in ZAP1164 This study
ZAP833 Allelic exchange of papACFT073 P1::gfp from pMT32 in ZAP957 This study
ZAP834 Allelic exchange of papACFT073 P2::gfp from pMT22 in ZAP957 This study
ZAP838 Allelic exchange of papACFT073 P1::lacZ from pMT31 in ZAP957 This study
ZAP843 Allelic exchange of papACFT073 P1::lacZ from pMT31 in ZAP964 This study
ZAP955 Allelic exchange of papACFT073 P2::gfp from pKC10 in ZAP1164 This study
ZAP964 Intermediate allelic-exchange strain with sacB-neo cassette placed in the lac locus of ZAP965 This study
ZAP965 Intermediate strain with sacB-neo removed from ZAP966 to generate 
papI-BCFT073 P2

papI-B
CFT073 P1
This study
ZAP966 Intermediate strain with sacB-neo cassette placed in papI-BCFT073 P2 of ZAP969 This study
ZAP969 Intermediate strain with sacB-neo removed from ZAP972 to generate 
papI-BCFT073 P1 This study
ZAP972 Intermediate strain with sacB-neo cassette placed in papI-BCFT073 P1 of CFT073 This study
ZAP992 Allelic exchange of papACFT073 P1::lacZ from pKC41 in ZAP1164 This study
ZAP996 Allelic exchange of papAJ96F13::lacZ from pKC37 in ZAP957 This study
ZAP1137 Allelic exchange of papACFT073 P2::lacZ from pMT06 in ZAP957 This study
ZAP1164 Intermediate allelic-exchange strain, lacZYA replaced with sacB-neo cassette in MG1655 38
Plasmids
pUC18 Commercial cloning vector (Ampr) (NEB, United States) Our stock
pBR322 Commercial cloning vector (Ampr) (NEB, United States) Our stock
pACYC184 Commercial cloning vector (Cmr) (NEB, United States) Our stock
pPap5 pBR322 with J96 F13 pap cluster, Apr 28
pAJR25 pIB307 with MG1655 lacI and lacA regions 38
pAJR28 pAJR25 with promoterless gfp gene placed between MG1655 lacI and lacA 20
pAJR32 pAJR25 with sac-kan cassette placed between MG1655 lacI and lacA 38
pAJR36 pAJR25 with promoterless lacZ gene placed between MG1655 lacI and lacA 38
pAJR145 pACYC184 with rpsM::gfp transcriptional fusion, Cmr 41
pHGM98 pACYC184 with inducible papI, Tcr 14
pIB307 Allelic-exchange temperature-sensitive vector, pSC101 replicon, Cmr 5
pIB462 pIB307 with MG1655 lac flanking regions 5
pKC8 pIB307 with CFT073 lacI and lacA regions 20
pCK10 pAJR28 with papI-ACFT073 P2 placed between MG1655 lacI and lacA This study
pKC11 pKC8 with sac-kan cassette placed between CFT073 lacI and lacA 20
pKC26 pAJR145 with rpsM removed This study
pKC29 pKC8 with promoterless lacZ placed between CFT073 lacI and lacA This study
pKC37 pKC29 with papI-AJ96 F13 placed between CFT073 lacI and lacA This study
pKC41 pAJR36 with papI-ACFT073 P1 placed between MG1655 lacI and lacA This study
pKC47 pKC8 with promoterless gfp placed between CFT073 lacI and lacA This study
pLD1 pIB462 with 9.6-kb fragment containing the papJ96 F13 cluster from pPap5 subcloned into
EcoRI-BamHI sites
This study
pLD7 pAJR36 with papI-AJ96 F13 placed between MG1655 lacI and lacA This study
pMT01 pAJR28 with papI-ACFT073 P1 placed between MG1655 lacI and lacA This study
pMT06 pKC29 with papI-ACFT073 P2 placed between CFT073 lacI and lacA This study
pMT11 pIB307 with sac-kan cassette placed between papCFT073 P1 flanking regulatory regions This study
pMT17 pIB307 with sac-kan cassette placed between papCFT073 P2 flanking regulatory regions This study
pMT22 pKC8 with papI-ACFT073 P2 placed between CFT073 lacI and lacA This study
pMT24 pKC26 with papICFT073 P1 promoter fused to gfp This study
pMT31 pKC29 with papI-ACFT073 P1 placed between CFT073 lacI and lacA This study
pMT32 pKC47 with papI-ACFT073 P1 placed between CFT073 lacI and lacA This study
pNJH107 pUC18 with upstream and downstream papCFT073 P1 flanking regulatory regions This study
pNJH117 pUC18 with upstream and downstream papCFT073 P2 flanking regulatory regions This study
Primersb
J96 P for 5-CGCGGATCCGGCCATGCAGTAAAACCGG pLD7
J96 P rev 5-CGGGTACCCCCCTGTGGAATAGTTGGAG
Continued on following page
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(23) and CFT073 (31), and compared with P fimbriation in an
E. coli K-12 derivative containing a complete pap operon.
Measurements were obtained using single colonies cultured on
CFA medium, culture conditions known to promote P fimbria
expression (13, 20). Colonies of the pyelonephritis isolate E.
coli J96 (Fig. 1A to C) were shown by flow cytometry to contain
an average of 18%  2% P-fimbriate bacteria labeled with a
polyclonal anti-PapA antiserum (32). In E. coli CFT073, the
positive proportion determined by flow cytometry was found to
be 4.8%  0.4% using an anti-P polyclonal serum (Fig. 1F),
OM12 (35). This percentage is an underestimate as this poly-
clonal serum caused a degree of bacterial aggregation. Count-
ing P-fimbria-positive bacteria by immunofluorescence micros-
copy produced proportions between 10 and 20% depending on
the colony measured (Fig. 1D and E). For comparison to assess
fimbriation levels in E. coli clinical isolates, the complete F13
pap operon (papI-papG) from E. coli J96 (28, 30) was inserted
into the E. coli K-12 chromosome at the lac locus, generating
ZAP594 (Table 1). In this strain, only 0.26%  0.02% of the
bacterial population fell within the gate for fluorescence de-
tection (Fig. 1I). While this value is at the limit of detection by
flow cytometry, positively stained bacteria were clearly detect-
able by microscopy at a low frequency (micrographs are shown
in Fig. 1G and H), and the geometric mean for the gated
population (Fig. 1I) was higher than that for a negative control
(data not shown). E. coli MG1655 transformed with pPap5, a
multicopy plasmid that contains the complete F13 pap operon
from E. coli J96, was included as a positive control and resulted
in an 82.8%-positive subpopulation with the anti-PapA anti-
serum (Fig. 1L).
Reporter fusions to GFP reflect fimbriation levels in clinical
isolates and the E. coli K-12 background. Green fluorescent
protein (GFP) reporter fusions to both the E. coli CFT073 pap
operons (P1 and P2) were made and inserted into both the E.
coli CFT073 and E. coli K-12 chromosomes at lac, generating
strains ZAP833 and ZAP834 and strains ZAP714 and
ZAP955, respectively (Table 1). The pap regulatory regions
used included both papI and papB and the first codon of papA
(Fig. 2). The proportions of fluorescent bacteria were then
determined by flow cytometry. The proportions of E. coli
CFT073 cells expressing P1 and P2 papA::gfp were 24% 
1.9% and 32%  3.6%, respectively. In contrast, the propor-
tions of E. coli K-12 cells expressing P1 and P2 papA::gfp were
0.23%  0.04% and 0.37%  0.13%, respectively. These data
confirmed that there were marked differences in P fimbria
expression levels between the E. coli CFT073 and E. coli K-12
genetic backgrounds.
Measurement of pap phase transition frequencies in E. coli
CFT073. In order to measure phase transition frequencies in a
clinical isolate background, fusions of the E. coli CFT073 P1
and P2 and E. coli J96 F13 regulatory regions to lacZ were
made and inserted into the E. coli CFT073 chromosome at lac,
generating ZAP838, ZAP1137, and ZAP996, respectively. The
J96 pap operon fusion phase varied at a high frequency, 1 
102 per cell per generation. The off-to-on phase transition
frequency of the CFT073 P1 operon was 4.4  103  0.3 
103 per cell per generation, and the off-to-on phase transition
frequency was 6.1  103  0.6  103 per cell per generation
for the P2 operon. For comparison, a fusion to P1 was con-
structed in E. coli K-12, and the off-to-on frequency deter-
mined was 1  105 per cell per generation. Phase transition
was also measured in the on-to-off direction and was 3.3 
102  0.08 102 per cell per generation for CFT073 P1 and
3.5  102  0.02  102 per cell per generation for P2 in the
CFT073 background. These on-to-off frequencies were found
to be consistent when they were measured under a number of
different conditions (data not shown).
Correlation of fimbriation levels and phase transition fre-
quencies. In the current study the frequencies of P phase vari-
ation were determined, as were the proportions of fimbriate
bacteria in both E. coli K-12 and clinical isolate backgrounds.
As these two parameters are linked, the proportion of fimbri-
ate bacteria in the population can be calculated from phase
transition frequencies and vice versa. Figure 3 shows the ex-
TABLE 1—Continued
Strain, plasmid,
or primer Genotype or sequence
Reference, source,
or use
CFT P1 for 5-CGCGGATCCGAAGTTTATGGCGTTTGTATTTTG pMT01
CFT P1 rev 5-CGGGTACCCCCCTGAGGAATAGTTGG
CFT P2 for 5-CGCGGATCCCTGATTCGTCATTCTATTCTTATTGA pKC10
CFT P2 rev 5-CGGGTACCGCCTTGAGGGATAGATGCA
CFTP12 for 5-CGCGGATCCGTTTCAGTGAAGCATGCCCAC pMT32, pMT22,
CFTP12 rev 5-CGGGTACCCATAAATAACAACCTCTTTTTCATTAC pMT21, pMT06
papIP1for 5-CGCTCTAGACATATATTCACTCATCTCACTG pMT24
papIP1rev 5-CGCTCTAGAGTTTCCCCCTTCTGTCGGGC
P1UPfor 5-GCTGAGCTCCGGTTCAGTAATATCTGA pNJH107
P2UPfor 5-GCTGAGCTCGTGCCGACGATCCCCTGA pNJH117
P12SUPrev 5-GCTGGATCCTTCACTGAAACAGATAAAWGT pNJH107, pNJH117
P12DNfor 5-CGGGATCCATGGTACCTCGGTTATTGCCGGTGCG pNJH107, pNJH117
P1DNrev 5-CGCTCTAGACCATCTTTTCTGACGGCAGC pNJH107
P2DNrev 5-CGCTCTAGACTATTATCTTTCTTAACAAATGC pNJH117
a M. S. Guyer, R. R. Reed, J. A. Steitz, and K. B. Low, presented at the Cold Spring Harbor Symposium on Quantitative Biology, 1981.
b Restriction sites are underlined.
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pected proportions of phase-on (fimbriate) bacteria in colonies
plotted against the number of generations. These proportions
were calculated using a range of off-to-on transition frequen-
cies and a single on-to-off frequency of 3 102 per cell per
generation that was based on the measurements obtained in
this study. From this information, it can be estimated that the
two pap operons in J96 turn on at a combined frequency of
1  102 per cell per generation, while the pap operons in E.
FIG. 1. Immunofluorescence microscopy and flow cytometry of P fimbriation in different E. coli strains. (A, D, G, and J) Phase-contrast images.
(B, E, H, and K) Fluorescence images. (C, F, I, and L) Flow cytometry histograms. The gate for fluorescence detection is indicated by M1 and
was set as defined in Materials and Methods. The proportion of fluorescent events is indicated in the upper right corner of each histogram. (A,
B, and C) E. coli J96; (D, E, and F) E. coli CFT073; (G, H, and I) E. coli ZAP594; (J, K, and L) E. coli MG1655 transformed with pPap5. For
panel H, multiple fields had to be scanned to detect a single P-fimbria-positive bacterium, indicating the low F13 Pap off-to-on transition frequency
in the E. coli K-12 background.
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coli CFT073 vary from off to on at a frequency between 3 
103 and 1  102 per cell per generation. In comparison, the
estimated frequency for the single J96-derived operon in the E.
coli K-12 background was 1  104 per cell per generation
based on 0.26% fimbriation. These frequency estimates based
on fimbriation levels are in agreement with the actual transi-
tion frequencies measured using the papA::lacZ fusions.
Environmental signals have differential effects on off-to-on
transition frequencies of P1 and P2 pap operons from E. coli
CFT073. Previous research has shown that pap regulation is
responsive to a number of environmental signals in an E. coli
K-12 background, such as carbon source and temperature (7).
In addition, recent studies have suggested that there is differ-
ential regulation of these pap clusters in human urine and
during murine UTI (43). We therefore wanted to investigate
the effect of environmental signals on the transition frequen-
cies of the two pap operons from CFT073 (P1 and P2) in the
context of the clinical isolate background. Frequencies were
determined using the P1 and P2 lacZ reporter fusions
(ZAP838 and ZAP1137, respectively [Table 1]). Table 2 shows
the phase transition frequencies for CFT073 P1 and P2 pap
operons in the off-to-on orientation when organisms were cul-
tured under different conditions. In contrast to the results
obtained with a complex medium (CFA medium), the off-to-on
transition frequencies were lower in defined media (Table 2).
As expected based on previous results, both operons were
catabolite repressed to similar extents (Table 2); the decrease
was highly significant for both P1 and P2 papA::lacZ fusions
(P  0.001). The frequencies were also higher in the presence
of amino acids (Table 2), although P1 was more responsive
(fourfold) than P2 (twofold) (P  0.001 and P  0.03, respec-
tively). A temperature decrease from 37 to 28°C only moder-
ately affected the P1 transition frequency and had no effect on
P2 (Table 2). However, it was noted that the phase-on colonies
were paler, perhaps indicating that there were reduced tran-
scription initiation levels at 28°C, despite the fact that there
was no effect on the off-to-on phase transition frequency.
The effect of human urine on phase transition frequencies of
E. coli CFT073 P1 and P2 was measured on plates at 37°C
(Table 2) and in static liquid urine at 37°C (Table 2). On urine
plates the off-to-on frequencies for P1 were equivalent to those
on CFA medium, whereas the frequency for P2 was approxi-
mately fivefold lower. The frequency was significantly higher
for P1 (P 0.001). In liquid urine the frequencies were slightly
lower than those on plates, although the difference between P1
and P2 was still evident. On-to-off phase transition frequencies
were determined on urine plates (Table 2) and were similar to
those measured on CFA medium (approximately 3  102 per
cell per generation [see above]). The phase-off transition fre-
quency on urine plates was marginally higher for P2 (1.5 
102 per cell per generation) than for P1 (1 102 per cell per
generation). Taken together, these results indicate that P1 is
expressed at higher levels than P2 in human urine.
PapI in trans can increase the pap off-to-on transition fre-
quency in the E. coli K-12 background. PapI is an established
positive regulator of pap off-to-on phase transition (2, 18, 24,
33). Changes in the amount of PapI may explain the back-
ground differences reported in this study, and in a clinical
isolate background these differences may arise as a conse-
quence of the presence of multiple pap operons and/or as a
consequence of differences in the regulatory network that dif-
ferentially affect expression from each operon. To determine
whether increasing papI expression in E. coli K-12 could in-
crease pap off-to-on phase transition frequencies and fimbria-
tion, plasmid-based papI was transformed into two E. coli K-12
strains, one containing an integrated single-copy fusion of the
J96 F13 pap regulatory region to lacZ (ZAP593 [Table 1]) and
the other containing the complete J96 F13 pap operon
(ZAP594 [Table 1]). The off-to-on transition frequency in-
creased 34-fold in the presence of induced PapI (Fig. 4A). This
correlated well with the 53-fold increase in the proportion of
P-fimbriate bacteria detected using immunostaining and flow
cytometry (Fig. 4B). Taken together, these data suggest that
low PapI levels in the E. coli K-12 background could in part
explain the lower off-to-on phase transition frequencies in this
background.
Effect of multiple pap operons on pap phase transition fre-
quencies in E. coli CFT073. To investigate whether the pres-
ence of two papI gene copies in the CFT073 chromosome is
responsible for the higher pap expression observed in this iso-
late, a CFT073 mutant strain in which both P1 and P2 regula-
tory regions and regulators were deleted was constructed. The
P1 and P2 lacZ reporter fusions were then assayed in this
background (ZAP843 and ZAP595, respectively [Table 1]).
FIG. 2. Genetic organization of pap gene cluster regulatory region.
The open reading frames for papI, papB, and papA are shown, together
with the promoter regions for papBA and papI. The black bars repre-
sent the distal and proximal GATC Dam methylation sites, and the
gray bars represent the Lrp binding sites. The region used for regula-
tory fusions to LacZ and GFP is also shown.
FIG. 3. Correlation between the proportion of phase-on bacteria in
a population and phase transition frequencies. Different frequencies of
off-to-on phase transition were plotted against the number of genera-
tions, using a constant on-to-off transition frequency of 3  102 per
cell per generation. The resultant proportions of the population that
are phase-on are expressed as percentages of the total population. The
phase-on transition frequencies used for the correlation are indicated
as follows (with the expected percentages of phase-on bacteria at
equilibrium in parentheses): F, 1  102 per cell per generation
(25%); , 6  103 per cell per generation (16.7%); , 3  103 per
cell per generation (9.09%); Œ, 1  103 per cell per generation
(3.2%); f, 5  104 per cell per generation (1.64%); and }, 1  104
per cell per generation (0.33%). All cultures would take more than 200
generations to reach an apparent steady state.
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The off-to-on transition frequency on CFA medium for P1 was
reduced slightly from 4.4  103 per cell per generation in the
CFT073 wild-type background to 3.3  103 per cell per gen-
eration in the CFT073 mutant background, while for P2 there
was a 2.4-fold reduction from 6.1  103 to 2.6  103 per cell
per generation (P  0.001). When the P1 and P2 lacZ reporter
fusions in the CFT073 mutant background were assayed under
alternative conditions (28°C, RD M9 medium containing glyc-
erol), the impact of the genetic background was again more
evident in the P2 fusion. The off-to-on transition frequency for
the P2 fusion was reduced eightfold, while the P1 frequency
was reduced twofold. While these data indicate that there was
some cross-regulation by the homologous regulators, they can-
not account for the marked background differences between
the E. coli K-12 and CFT073 strains demonstrated in this study.
To investigate whether the background affected papI expres-
sion per se, a plasmid-based transcriptional fusion of the P1
papI promoter region to gfp was transformed in E. coli K-12,
wild-type strain CFT073, and the CFT073 pap regulatory re-
gion mutant strain. Expression of papI was higher (4.4-fold) in
both wild-type strain CFT073 and the pap regulatory region
mutant of CFT073 (Fig. 5) than in E. coli K-12. Increased
activation of papI in the clinical isolate background in combi-
nation with cross-regulation with homologous clusters ac-
counted for the observed P fimbriation in E. coli CFT073
and J96.
DISCUSSION
P fimbriae are an established virulence factor utilized by
UPEC to promote colonization of urinary and gastrointestinal
tracts (22, 36, 40, 47). Like expression of most fimbrial ad-
hesins produced by E. coli, expression of Pap is phase variable.
The mechanism underlying the variation and the genetic and
environmental inputs that affect it have been the focus of many
years of research. The majority of the studies have been carried
out on regulatory regions cloned into the E. coli K-12 chromo-
some, and the frequencies of phase transition have been de-
termined using lacZ fusions in this nonnative background (i.e.,
a background that does not normally support expression of a
pap cluster) (7). The current study reports for the first time
regulation of P-fimbrial phase transition frequencies in a
UPEC strain and demonstrates the importance of the genetic
background for these frequencies. In particular, high off-to-on
transition frequencies may be accounted for by elevated papI
expression levels.
Early studies using immunoelectron microscopy and indirect
immunofluorescence reported high levels of P fimbria expres-
sion in UPEC isolate populations cultured in vitro and dem-
onstrated that phase variation was extremely rapid, although
no actual frequency measurements were obtained. The pyelo-
nephritis E. coli isolate KS71 possesses two pap operons and,
when it was cultured on CFA agar, 17% of the population had
P fimbriae (43). A different UPEC strain, C1212, also carrying
two pap operons, produced colonies in which 84% of the bac-
teria expressed P fimbriae, although in this case one cluster
(pilin-21) was dominant (29). Pere et al. showed that popula-
tions of E. coli strains found in urine from patients with symp-
tomatic UTI were between 0.01 and 95% P fimbriate (36).
FIG. 4. Effect of addition of papI in trans on pap phase transition
and fimbriation. (A) Off-to-on phase transition frequency of strain
ZAP593. (B) Fimbriation of strain ZAP594 stained with anti-PapA
antibody, determined by flow cytometry. In both cases the strains were
transformed with pACYC184 (control) or pHMG98 (papI).
FIG. 5. Expression of papI::gfp plasmid-based fusion. Expression
from the fusion is shown for pMT24 transformed into E. coli K-12,
CFT073, and ZAP965. The background fluorescence level determined
for pKC26 in each strain was subtracted from the corresponding level
for pMT24. The data are expressed in relative fluorescence units
(RFU).
TABLE 2. Phase transition frequencies of Pap clusters P1 and P2 from E. coli CFT073, measured under different environmental conditions
as described in Materials and Methodsa
Conditions
Off-to-on transition frequency (103 per
cell per generation) (SEM)
On-to-off transition frequency (103 per cell
per generation) (SEM)
P1 cluster P2 cluster P1 cluster P2 cluster
RD M9 glycerol medium, 37°C 1.92 (0.14) 1.01 (0.12)
RD M9 glucose medium, 37°C 0.94 (0.11) 0.32 (0.05)
Minimal M9 glycerol medium, 37°C 0.79 (0.19) 0.60 (0.11)
RD M9 glycerol medium, 28°C 1.25 (0.20) 1.02 (0.08)
Static urine, 37°C 2.55 (0.31) 1.25 (0.14)
Urine plates, 37°C 4.31 (0.53) 1.28 (0.22) 10.16 (2.02) 14.74 (1.00)
CFA medium, 37°C 4.36 (0.26) 6.12 (0.64) 32.60 (0.79) 35.30 (1.77)
a Frequencies were determined from at least six different colonies derived from 22 to 28 generations, depending on the conditions tested.
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Overall, the reported high levels of P fimbria expression pre-
dict that the pap off-to-on transition frequencies in UPEC
strains are higher than the frequencies determined in the E.
coli K-12 background (7). These studies reported pap frequen-
cies of 1 in 10,000 cells transitioning from phase off to phase on
in each generation. This frequency would generate a popula-
tion in which less than 1% of the cells are phase on (Fig. 3),
which is not large enough to account for the P-fimbriate sub-
populations reported in the studies described above (29, 34).
To address this question in detail, phase transition frequen-
cies were determined for the two Pap clusters present in E. coli
CFT073 using lacZ and gfp fusions to the papI-papBA regula-
tory regions. As anticipated (2, 7, 16, 50), the frequencies were
dependent on the culture conditions but ranged from 6  104
per cell per generation on minimal M9 glycerol medium to 6 
103 per cell per generation on CFA medium. On-to-off tran-
sition frequencies were also measured and remained fairly
constant at 3  102 per cell per generation. Based on these
frequencies, the expected proportion of fimbriate bacteria cul-
tured on CFA medium would be between 10 and 30% depend-
ing on the amount of cross-regulation between the two clusters
and the rate at which bacteria that turn off expression lose
fimbriae from their surfaces. The predicted level of fimbria-
tion, based on the measured frequencies, was entirely consis-
tent with the level of fimbriation detected for E. coli CFT073 in
the present study (10 to 20%) (Fig. 1C and D). It should be
noted that construction of the chromosomally integrated re-
porter fusions does introduce an extra copy of the regulatory
region into E. coli CFT073 but that the rates and levels of
expression were consistent with fimbriation under the condi-
tions tested.
P1 and P2 are homologous pap clusters in E. coli CFT073,
and both encode a PapG class II adhesin. Here we demon-
strate that these clusters are differentially regulated by certain
environmental conditions. The P1 cluster was more responsive
to amino acids and temperature. By contrast, both clusters
showed the same level of catabolite repression. Urine has been
shown to contain levels of amino acids high enough to support
bacterial growth, and the increased off-to-on phase transition
frequency of P1 relative to that of P2 may be due to an amino
acid response (1). In addition, the P2 on-to-off transition fre-
quency was higher, indicating that the overall fimbriation level
was higher for P1 in human urine. This is the first time that
phase transition frequencies have been determined for a
UPEC isolate cultured in human urine, the physiological en-
vironment most similar to human UTI.
The off-to-on phase transition frequencies determined in the
current study are similar to those determined for type 1 fim-
briae. While type 1 fimbriae are regulated by a totally different
phase-variable mechanism, the off-to-on transition frequencies
at 37°C are between 8  104 and 9  103 per cell per
generation, depending on the culture conditions (15). When
the data are taken together, it may be that this range of fre-
quencies is optimal for maintaining surface factor heterogene-
ity in populations and persistence during colonization and in-
fection. Studies of diverse phase-variable systems have also
shown similar levels of phase variation frequencies. For exam-
ple, slip-stranded mispairing is a mechanism used for generat-
ing variation and is common in Haemophilus influenzae and
Neisseria meningitidis. The frequencies were shown to be in the
range from 2  104 to 5  103 per cell per generation,
depending on the genetic background (46). Only one instance
of slip-stranded mispairing has been reported as a mechanism
for variation in E. coli, for the AhpC enzyme. The frequency of
variation was shown to be in the same range, as demonstrated
for phase variation of fimbrial clusters (0.5  103 per cell per
generation) (39).
The present study showed that pap clusters exhibit signifi-
cantly reduced frequencies of phase variation when they are
measured in an E. coli K-12 background. This background
difference was confirmed using a complete pap cluster inserted
into the E. coli K-12 chromosome at lac. The fimbriation levels
of this strain were 100-fold lower than those of the parental
strain, J96 (Fig. 1). Based on our current understanding of the
pap phase variation mechanism (4), all the required regulators
are present in both backgrounds. The higher frequency in the
clinical isolate must be explained by altered levels of one or
more of the established regulators or novel regulators of the
system. While off-to-on transition frequencies were much
higher in the isolate background, the transition frequencies in
the opposite direction were equivalent. This indicates that the
difference is due to a factor or factors that promote only off-
to-on phase transition. A key candidate is the positive regula-
tor PapI. Higher total levels of PapI could be achieved by
increased expression from individual papI promoters and/or by
the presence of multiple homologous pap clusters and there-
fore an increased papI copy number. To determine the signif-
icance of cross-activation in the clinical isolate background, the
two papI-papBA regulatory regions from P1 and P2 in E. coli
CFT073 were deleted, and expression of pap from a regulatory
region fusion engineered into the lac locus was examined.
Deletion of the pap regulatory regions made no significant
difference to the off-to-on phase transition of P1 but did reduce
the P2 transition frequency. These results indicate that cross-
activation between P fimbira-related clusters alone cannot ac-
count for the frequency differences in the different back-
grounds. Subsequently, papI expression was measured in the
two backgrounds and was shown to be higher in the clinical
isolate than in E. coli K-12. Furthermore, papI expression was
the same in the papI-papBA double deletion strain, which sug-
gests that signals over and above native pap regulators influ-
ence papI expression in the clinical isolate. While plasmid copy
number or GFP stability differences may account for the higher
apparent expression level in E. coli CFT073, elevated papI
expression would explain the higher off-to-on phase transition
rates and fimbriation levels observed in the clinical isolate
background. Not surprisingly, the results also indicate that the
regulatory network controlling papI expression is different in a
clinical isolate, and this is likely to be due to both the evolution
of common signal transduction systems and regulatory cross
talk with other specifically acquired virulence determinants
and their regulators. At present, there is little published re-
search on the regulation of papI, and further work is required
in this area.
Phase-variable expression of P fimbriae has two proposed
roles in aiding UPEC colonization of the human urinary tract.
As P fimbriae are surface antigens, phase variation is thought
to limit immune exposure of the specific antigen and assist in
evasion of innate and adaptive host responses (25, 44). At the
same time, phase variation generates a heterogeneous bacte-
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rial population with a subpopulation of P-fimbriate bacteria
that are equipped to colonize cells expressing Gal-(1-4)-Gal
receptors (26–28). Another proposed function of phase varia-
tion is to coordinate expression of surface factors that are
required in complex microenvironments, such as the colonized
epithelium (19). Surface factors can block or hinder each
other, and so clusters expressing surface factors, such as fim-
brial adhesins, nonfimbrial adhesins, flagella, outer membrane
proteins, and capsule, are connected via a regulatory network
that is driven in part by phase variation (17). Phase variation
frequencies, therefore, not only are important to control ex-
pression levels of a specific local factor but also impact the
regulation of a wide spectrum of other surface components
expressed during infection.
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